Identifying Priority Areas for Increasing the Supply of Medication-Assisted Treatments for Opioid Use Disorder: A Geospatial Approach

Author:

Topmiller Michael,Mallow Peter,Vissman Aaron,Grandmont Jene

Abstract

Background: The opioid epidemic has disproportionately affected several areas across the United States (US), with research indicating that these areas may be underserved and lack access to sufficient medication-assisted treatment (MAT) options. The objective of this study was to introduce a geospatial analytical framework for identifying sub-state priority areas to target federal allocation of MAT training and resources. Methods: We used a geospatial analytical framework, which integrated multiple substance use measures and layers of geographic information. Measures included estimates of illicit drug dependence and unmet treatment need from the National Survey on Drug Use and Health (NSDUH), opioid-related admissions from the Treatment Episode Data Set: Admissions (TEDs-A), and Drug Enforcement Agency (DEA) waiver practitioner data from the Substance Abuse and Mental Health Services Administration (SAMHSA). Analyses included standard deviation outlier mapping, local indicators of spatial autocorrelation (LISA), and map overlays. Results: We identified twenty-nine opioid dependence priority areas, eleven unmet treatment need priority areas, and seven low MAT capacity priority areas, located across the US, including southeastern Ohio, western Indiana, the District of Columbia, New England, and northern and southern California. Conclusions: This study identified several areas across the US that have unmet need for MAT. Targeting these areas will allow for the most effective deployment of cost-effective MAT resources to aid the greatest number of patients with opioid use disorders.

Publisher

The Journal of Health Economics and Outcomes Research

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference27 articles.

1. Substance Abuse and Mental Health Services Administration (SAMHSA). Key substance abuse and mental health indicators in the United States: Results from the 2015 National Survey on Drug Use and Health. Published online 2016. Accessed February 6, 2018. http://www.samhsa.gov/data

2. Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357(j1550). doi:10.1136/bmj.j1550

3. Kessel JB, Castel LD, Nemecek DA. Clinical and cost outcomes of buprenorphine treatment in a commercial benefit plan population. Am J Pharm Benefits. 2018;10(1):e1-e6.

4. Cost-effectiveness of publicly funded treatment of opioid use disorder in California;Krebs;Ann Intern Med,2018

5. Murphy S, Polsky D, Meisel Z, Mitchell J. Show me the money: Economic evaluations of opioid use disorder interventions. LDI Issue Briefs. Published online 2016. Accessed February 6, 2018. https://ldi.upenn.edu/brief/show-me-money-economic-evaluations-opioid-use-disorder-interventions

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3